Arcutis Biotherapeutics, Inc. (ARQT)
USD 13.4
(-9.83%)
USD 13.4
(-9.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 59.6 Million | 3.68 Million | - | - | - | - |
| Cost of Revenue | 4.98 Million | 754 Thousand | 763 Thousand | 455 Thousand | 195 Thousand | - |
| Gross Profit | 54.61 Million | 2.93 Million | -763 Thousand | -455 Thousand | -195 Thousand | - |
| Operating Expenses | 295.72 Million | 304.55 Million | 206.52 Million | 136.64 Million | 43.13 Million | 19.73 Million |
| Selling, General and Administrative Expenses | 185.14 Million | 122.12 Million | 60.97 Million | 21.33 Million | 6.61 Million | 1.79 Million |
| Research and Development Expenses | 110.57 Million | 182.43 Million | 145.55 Million | 115.3 Million | 36.52 Million | 17.94 Million |
| Other Expenses | - | 5.82 Million | 173 Thousand | 967 Thousand | 1.13 Million | 480 Thousand |
| Cost and Expenses | 300.7 Million | 305.31 Million | 206.52 Million | 136.64 Million | 43.13 Million | 19.73 Million |
| Operating Income | -241.1 Million | -301.62 Million | -206.52 Million | -136.64 Million | -43.13 Million | -19.73 Million |
| Interest Expense | 29.71 Million | 15.65 Million | - | - | - | - |
| Income Tax Expense | 3.11 Million | 9.83 Million | -454 Thousand | -84.29 Thousand | 23.14 Thousand | -480 Thousand |
| Earnings before Tax | -259.02 Million | -311.45 Million | -206.35 Million | -135.67 Million | -41.99 Million | -19.25 Million |
| Net Income | -262.14 Million | -321.28 Million | -205.9 Million | -135.67 Million | -41.99 Million | -19.25 Million |
| Earnings Per Share Basic | -3.78 | -5.84 | -4.17 | -3.80 | -1.10 | -0.53 |
| Earnings Per Share Diluted | -3.78 | -5.84 | -4.17 | -3.80 | -1.10 | -0.53 |
| Weighted Average Shares Outstanding | 69.3 Million | 55.03 Million | 49.4 Million | 35.66 Million | 38.08 Million | 36.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.3 Million | 55.03 Million | 49.4 Million | 35.66 Million | 38.08 Million | 36.23 Million |
| Gross Margin | 0.92 | 0.80 | - | - | - | - |
| EBIT Margin | -3.82 | -80.25 | - | - | - | - |
| Profit Margin | -4.40 | -87.16 | - | - | - | - |
| EBITDA | -227.43 Million | -294.55 Million | -205.59 Million | -135.22 Million | -41.8 Million | 480 Thousand |
| Earnings Before Tax Margin | -4.04 | -81.83 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 30.85 Million | 49.56 Million | 59.6 Million | 13.52 Million | 38.1 Million | 5.19 Million |
| Cost of Revenue | 3.46 Million | 3.25 Million | 6.11 Million | 2.44 Million | 1.18 Million | 776 Thousand |
| Gross Profit | 27.39 Million | 46.31 Million | 53.48 Million | 11.08 Million | 36.92 Million | 4.41 Million |
| Operating Expenses | 77.47 Million | 77.93 Million | 294.58 Million | 72.25 Million | 73.83 Million | 71.17 Million |
| Selling, General and Administrative Expenses | 58.17 Million | 54.79 Million | - | 48.47 Million | 47.59 Million | 45.95 Million |
| Research and Development Expenses | 19.29 Million | 23.14 Million | - | 23.77 Million | 26.23 Million | 25.21 Million |
| Other Expenses | 5.22 Million | 4.04 Million | 11.78 Million | 2.67 Million | 2.72 Million | 3.12 Million |
| Cost and Expenses | 80.93 Million | 81.19 Million | 300.7 Million | 74.69 Million | 75.01 Million | 71.95 Million |
| Operating Income | -50.07 Million | -31.62 Million | -241.1 Million | -61.16 Million | -36.9 Million | -66.76 Million |
| Interest Expense | 7.48 Million | 7.48 Million | 29.71 Million | 7.76 Million | 7.55 Million | 7.34 Million |
| Income Tax Expense | - | 324 Thousand | 3.11 Million | 25 Thousand | 3.02 Million | 10.08 Million |
| Earnings before Tax | -52.33 Million | -35.05 Million | -259.02 Million | -66.25 Million | -41.74 Million | -70.99 Million |
| Net Income | -52.33 Million | -35.38 Million | -262.14 Million | -66.28 Million | -44.76 Million | -70.99 Million |
| Earnings Per Share Basic | -0.42 | -0.32 | - | -0.72 | -0.73 | -1.16 |
| Earnings Per Share Diluted | -0.42 | -0.32 | - | -0.72 | -0.73 | -1.16 |
| Weighted Average Shares Outstanding | 123.48 Million | 111.04 Million | 69.3 Million | 92.58 Million | 61.72 Million | 61.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.48 Million | 111.04 Million | 69.3 Million | 92.58 Million | 61.72 Million | 61.43 Million |
| Gross Margin | 0.89 | 0.93 | 0.90 | 0.82 | 0.97 | 0.85 |
| EBIT Margin | -1.61 | -0.63 | - | -4.49 | -0.90 | -12.26 |
| Profit Margin | -1.70 | -0.71 | -4.40 | -4.90 | -1.17 | -13.68 |
| EBITDA | -49.72 Million | -31.26 Million | - | -60.78 Million | -34.18 Million | -63.64 Million |
| Earnings Before Tax Margin | -1.62 | -0.64 | -4.04 | -4.52 | -0.97 | -12.86 |
SMR-WT
BSPM
ANG
INDIANVSH
1008
300173